$100.00
10mg – Lyophilized *MUST BE RECONSTITUTED FOR RESEARCH APPLICATIONS*
Thymosin Alpha-1 10mg is a premium, high-purity synthetic 28-amino-acid peptide engineered to study potent immunomodulatory, T-cell maturation, and cellular defense cascades. By selectively targeting TLR2 and TLR9 pathways to activate NK cells and balance Th1 cytokine signaling without altering baseline physiological toxicity, this stable 10mg formulation stands as a premier investigative tool for tracking advanced immune restoration, antiviral mechanics, and targeted antigen presentation in laboratory models.
Supplied as a stable, premium-grade lyophilized powder in a single 10mg vial. Restricted strictly to laboratory and in vitro evaluation.
Eterna Peptides presents premium-grade Thymosin Alpha-1 (10mg) lyophilized powder, an advanced synthetic formulation of the endogenous highly conserved 28-amino-acid peptide. Naturally produced by thymic epithelial cells, Thymosin Alpha-1 functions as a master orchestrator of the adaptive and innate immune systems. Extensively investigated within molecular immunology, oncology, and virology, this precise 10mg presentation serves as an elite investigative tool for tracking T-cell differentiation kinetics, natural killer (NK) cell activation, and targeted cytokine signaling regulation.
### Mechanism of Action
Thymosin Alpha-1 operates as an upstream immune modulator, driving distinct cellular defense cascades:
* **T-Cell Differentiation and Maturation:** Ta1 interacts directly with toll-like receptors (primarily TLR2 and TLR9) on myeloid dendritic cells. This signaling cascade promotes the differentiation of pluripotent stem cells into mature, functionally active T-lymphocytes, shifting the helper T-cell balance toward an active Th1 response baseline.
* **Cytotoxic Lymphocyte & NK Cell Activation:** In cellular stress models, the peptide is monitored for its capacity to significantly upregulate the activity of Natural Killer (NK) cells and cytotoxic CD8+ T-cells, enhancing the experimental model’s ability to recognize and clear atypical or virally altered cell structures.
* **Dual Cytokine Modulation Architecture:** Thymosin Alpha-1 exhibits a smart, homeostatic balancing mechanism. Under immunodeficient modeling, it stimulates the production of pro-survival cytokines like Interferon-gamma (IFN-γ), IL-2, and IL-12. Conversely, in hyper-inflammatory or cytokine-storm models, it downregulates chronic inflammatory signals to mitigate severe tissue trauma.
* **MHC Class I & Antiviral Expression:** Preclinical data indicates Ta1 upregulates the expression of Major Histocompatibility Complex (MHC) Class I molecules and tumor antigens on target cells, vastly improving cellular antigen-presentation mechanics for targeted research evaluation.
### Research Applications
In preclinical and in vitro laboratory models, Thymosin Alpha-1 10mg vials are actively utilized to investigate:
* Advanced systemic immunomodulation, macrophage activation, and dendritic cell maturation kinetics.
* Antiviral cellular defense mechanisms, chronic intracellular pathogen clearance, and viral replication resistance.
* Synergistic oncological cell tracking, tumor microenvironment modification, and lymphocyte survival rates.
* The comparative baseline stability, peptide chain integrity, and reconstitution kinetics of thymic peptide variations.
Our Thymosin Alpha-1 vials undergo strict laboratory quality control, stabilization, and vacuum-drying guidelines to ensure absolute ingredient standardization, high chemical purity, and dependable experimental reproducibility.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
